31
Participants
Start Date
August 31, 2010
Primary Completion Date
November 30, 2011
Study Completion Date
November 30, 2013
3 Day Thiarabine
Starting dose 70 mg/m\^2 IV over 1 hour (±15 minutes) daily x 3
5 Day Thiarabine
Starting dose 40 mg/m2 IV over 1 hour (±15 minutes) daily x 5
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Access Pharmaceuticals, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER